Prospective Study
Copyright ©The Author(s) 2022.
Artif Intell Gastroenterol. Oct 28, 2022; 3(4): 105-116
Published online Oct 28, 2022. doi: 10.35712/aig.v3.i4.105
Table 1 Patients' characteristics (n = 29)
Male/Female16/13
Age (yr)56.4 ± 14.3
Body weight (kg)74.1 ± 13.1
BMI (kg/m2)28.4 ± 5.2
Metabolic diseases
Diabetes mellitus (Yes/No)10/19
Dyslipidemia (Yes/No)14/15
Concomitant drugs
SGLT2 inhibitor2
DPP-4 inhibitor3
Thiazolidinedione
GLP-1 agonist1
Statin7
Bezafibrate
Pemafibrate
EPA and DHA preparation1
AST (U/L)50.2 ± 33.4
ALT (U/L)53.8 ± 39.0
GGT (U/L)80.3 ± 84.3
T-B (mg/dL)1.3 ± 0.9
Alb (mg/dL)4.2 ± 0.6
eGFR (mL/min)71.1 ± 11.5
HbA1c (%)6.4 ± 0.8
T-cho (mg/dL)191.3 ± 35.0
TG (mg/dL)126.5 ± 57.8
WBC (103/μL)5.6 ± 1.5
Hb (g/dL)14.5 ± 1.7
Plts (104/μL)17.7 ± 7.4
Table 2 Changes of blood biochemistry parameters and body weight

Baseline
6M Follow-up
P value
AST (U/L)50.2 ± 33.434.7 ± 14.70.0088
ALT (U/L)53.8 ± 39.035.3 ± 16.80.0113
GGT (U/L)80.3 ± 84.366.3 ± 82.90.0494
HbA1c (%)6.4 ± 0.86.2 ± 0.60.27832
T-cho (mg/dL)191.3 ± 35.0189 ± 34.30.2109
TG (mg/dL)126.5 ± 57.8104.1 ± 60.60.0426
Body weight (kg)74.0 ± 13.171.2 ± 12.30.0472
Table 3 Number of photographed food items, analysis rate, and time for confirmation
Case
All foods
No of candidates
Analysis rate (%)
Time for confirmation (min)
1571377.2 25.0
231293.5 4.5
3903165.6 67.0
440782.5 20.5
5742073.0 31.0
669198.6 6.0
724387.5 9.5
820955.0 12.0
947980.9 28.5
10872966.7 35.5
11261253.8 14.0
1235877.1 10.0
13852570.6 36.5
1495891.6 8.5
15531571.7 20.0
16843261.9 39.5
17771383.1 14.0
1851786.3 13.0
19331651.5 20.0
20103991.3 19.5
2132681.3 5.5
22682563.2 32.5
23883065.9 50.0
24411856.1 66.0
25742270.3 36.0
261041684.6 34.0
27842273.8 47.5
28831384.3 25.5
29611378.7 20.5
Average62.6 15.0 75.1 25.9
Table 4 Questionnaire results
Question
Yes
No
1290
21514
3290
42529